Albemarle Optimizes Smallpox Drug Candidate For SIGA

Two American companies are teaming up for second-round test-phase production of a FDA-designated “fast track” drug candidate to treat smallpox, a deadly virus that is feared to be able to reach people through acts of bio-warfare or bio-terrorism.

More: continued here

Filed under: Bio-terrorism on May 15th, 2008